Rachel Anderson Heise, DO
Obstetrics & Gynecology · Lincoln, NENPI 1366837981
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,996 of the $3,420 with a category attached, or 87.6%. It is spread thinly across 28 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations.
Across 155 payments — averaging $22.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$732
- Astellas Pharma US Inc$530
- Medical Device Business Services, Inc.$325
- Sumitomo Pharma America, Inc.$251
- Gynesonics, Inc.$194
- Organon$150
- plus $1K from 22 others
What the payments were for
- Food & beverage$2,99688%
- Education$42412%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 44 | $732 |
| Astellas Pharma US Inc | 15 | $530 |
| Medical Device Business Services, Inc. | 1 | $325 |
| Sumitomo Pharma America, Inc. | 13 | $251 |
| Gynesonics, Inc. | 2 | $194 |
| Organon | 7 | $150 |
| Mayne Pharma Commercial LLC | 12 | $129 |
| Coopersurgical, Inc. | 6 | $111 |
| Biogen | 5 | $106 |
| Exeltis, USA Inc. | 6 | $98 |
| Daiichi Sankyo Inc. | 6 | $98 |
| Pfizer | 7 | $89 |
| Conmed Corporation | 1 | $80 |
| Therapeuticsmd, Inc. | 5 | $77 |
| Myovant Sciences Inc. | 5 | $75 |
| Virtual Incision Corporation | 2 | $56 |
| Bayer | 3 | $52 |
| Coloplast | 2 | $45 |
| Hologic Sales And Service, LLC | 2 | $40 |
| Merck | 2 | $35 |
| Johnson & Johnson | 1 | $29 |
| Exact Sciences | 2 | $26 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Boston Scientific | 1 | $19 |
| Scynexis, Inc. | 1 | $14 |
| Minerva Surgical, Inc | 1 | $14 |
| Evofem Biosciences, Inc. | 1 | $13 |
| Lilly USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,420 in reported general payments places this provider in the 85th percentile of 242 obstetrics & gynecology providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 20 | $1,059 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Lincoln
- Gregory HeidrickLincoln$80K
- Chandra LjunggrenLincoln$13K
- Emily NeriLincoln$13K
- Alicia MuhleisenLincoln$11K
- Todd MartinLincoln$8K
- Jenna van PeltLincoln$4K
- Darla Eisenhauer-SpiresLincoln$4K
- Jeffrey TomjackLincoln$3K
- Gary MiliusLincoln$3K
- Kathryn KlayumLincoln$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.